Home » Topics » Regulatory

Regulatory
RSS

Diovan approved in Sweden to treat high-risk heart attack patients

Dec. 3, 2004

Atacand approved in Europe for treatment of chronic heart failure

Nov. 30, 2004

Combunox approved for short-term management of acute moderate/severe pain

Nov. 30, 2004

Tysabri approved for multiple sclerosis

Nov. 25, 2004

Tarceva approved for advanced NSCLC

Nov. 22, 2004

Norditropin approved for adults with severe growth hormone deficiency

Nov. 9, 2004

New approval for Eloxatin

Nov. 9, 2004

New indication for Sandostatin injection approved in Japan

Oct. 29, 2004

European approval for Emselex

Oct. 28, 2004

CHMP adopts extension of indication for Schering-Plough HCV products

Oct. 27, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...